CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels

  1. André B Goncalves
  2. Sarah K Hasselbalch
  3. Beinta B Joensen
  4. Sebastian Patzke
  5. Pernille Martens
  6. Signe K Ohlsen
  7. Mathieu Quinodoz
  8. Konstantinos Nikopoulos
  9. Reem Suleiman
  10. Magnus P Damso Jeppesen
  11. Catja Weiss
  12. Søren Tvorup Christensen
  13. Carlo Rivolta
  14. Jens S Andersen
  15. Pietro Farinelli  Is a corresponding author
  16. Lotte B Pedersen  Is a corresponding author
  1. University of Copenhagen, Denmark
  2. Oslo University Hospital, Norway
  3. University of Southern Denmark, Denmark
  4. University of Basel, Switzerland
  5. University of Lausanne, Switzerland

Abstract

CEP78 is a centrosomal protein implicated in ciliogenesis and ciliary length control, and mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss. However, the mechanism by which CEP78 affects cilia formation is unknown. Based on a recently discovered disease-causing CEP78 p.L150S mutation, we identified the disease-relevant interactome of CEP78. We confirmed that CEP78 interacts with the EDD1-DYRK2-DDB1VPRBP E3 ubiquitin ligase complex, which is involved in CP110 ubiquitination and degradation, and identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78L150S mutation. We show that CEP350 promotes centrosomal recruitment and stability of CEP78, which in turn leads to centrosomal recruitment of EDD1. Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal. We propose that CEP78 functions downstream of CEP350 to promote ciliogenesis by negatively regulating CP110 levels via an EDD1-dependent mechanism.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 3A and Figure 7-figure supplement 2.

Article and author information

Author details

  1. André B Goncalves

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  2. Sarah K Hasselbalch

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Beinta B Joensen

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Sebastian Patzke

    Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  5. Pernille Martens

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  6. Signe K Ohlsen

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Mathieu Quinodoz

    Institute of Molecular and Clinical Ophthalmology Basel (IOB); Department of Ophthalmology, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Konstantinos Nikopoulos

    Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  9. Reem Suleiman

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  10. Magnus P Damso Jeppesen

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  11. Catja Weiss

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  12. Søren Tvorup Christensen

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5004-304X
  13. Carlo Rivolta

    Institute of Molecular and Clinical Ophthalmology Basel (IOB); Department of Ophthalmology, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Jens S Andersen

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  15. Pietro Farinelli

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    Pietro.Farinelli@twelve.bio
    Competing interests
    The authors declare that no competing interests exist.
  16. Lotte B Pedersen

    Department of Biology, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    lbpedersen@bio.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9749-3758

Funding

Independent Research Fund Denmark (8020‐00162B)

  • Pietro Farinelli
  • Lotte B Pedersen

Carlsberg Foundation (CF18‐0294)

  • Lotte B Pedersen

Independent Research Fund Denmark (8021-00425A)

  • Jens S Andersen

Swiss National Science Foundation (176097)

  • Carlo Rivolta

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jens Lüders, Institute for Research in Biomedicine, Spain

Publication history

  1. Preprint posted: October 5, 2020 (view preprint)
  2. Received: October 5, 2020
  3. Accepted: July 13, 2021
  4. Accepted Manuscript published: July 14, 2021 (version 1)
  5. Version of Record published: August 10, 2021 (version 2)

Copyright

© 2021, Goncalves et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,076
    Page views
  • 217
    Downloads
  • 5
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. André B Goncalves
  2. Sarah K Hasselbalch
  3. Beinta B Joensen
  4. Sebastian Patzke
  5. Pernille Martens
  6. Signe K Ohlsen
  7. Mathieu Quinodoz
  8. Konstantinos Nikopoulos
  9. Reem Suleiman
  10. Magnus P Damso Jeppesen
  11. Catja Weiss
  12. Søren Tvorup Christensen
  13. Carlo Rivolta
  14. Jens S Andersen
  15. Pietro Farinelli
  16. Lotte B Pedersen
(2021)
CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels
eLife 10:e63731.
https://doi.org/10.7554/eLife.63731

Further reading

    1. Cell Biology
    Yang Zhang et al.
    Research Article Updated

    TMEM16F, a Ca2+-activated phospholipid scramblase (CaPLSase), is critical for placental trophoblast syncytialization, HIV infection, and SARS-CoV2-mediated syncytialization, however, how TMEM16F is activated during cell fusion is unclear. Here, using trophoblasts as a model for cell fusion, we demonstrate that Ca2+ influx through the Ca2+ permeable transient receptor potential vanilloid channel TRPV4 is critical for TMEM16F activation and plays a role in subsequent human trophoblast fusion. GSK1016790A, a TRPV4 specific agonist, robustly activates TMEM16F in trophoblasts. We also show that TRPV4 and TMEM16F are functionally coupled within Ca2+ microdomains in a human trophoblast cell line using patch-clamp electrophysiology. Pharmacological inhibition or gene silencing of TRPV4 hinders TMEM16F activation and subsequent trophoblast syncytialization. Our study uncovers the functional expression of TRPV4 and one of the physiological activation mechanisms of TMEM16F in human trophoblasts, thus providing us with novel strategies to regulate CaPLSase activity as a critical checkpoint of physiologically and disease-relevant cell fusion events.

    1. Cancer Biology
    2. Cell Biology
    Johnny M Tkach et al.
    Research Article

    Centrosomes act as the main microtubule organizing center (MTOC) in metazoans. Centrosome number is tightly regulated by limiting centriole duplication to a single round per cell cycle. This control is achieved by multiple mechanisms, including the regulation of the protein kinase PLK4, the most upstream facilitator of centriole duplication. Altered centrosome numbers in mouse and human cells cause p53-dependent growth arrest through poorly defined mechanisms. Recent work has shown that the E3 ligase TRIM37 is required for cell cycle arrest in acentrosomal cells. To gain additional insights into this process, we undertook a series of genome-wide CRISPR/Cas9 screens to identify factors important for growth arrest triggered by treatment with centrinone B, a selective PLK4 inhibitor. We found that TRIM37 is a key mediator of growth arrest after partial or full PLK4 inhibition. Interestingly, PLK4 cellular mobility decreased in a dose-dependent manner after centrinone B treatment. In contrast to recent work, we found that growth arrest after PLK4 inhibition correlated better with PLK4 activity than with mitotic length or centrosome number. These data provide insights into the global response to changes in centrosome number and PLK4 activity and extend the role for TRIM37 in regulating the abundance, localization, and function of centrosome proteins.